TP53 and cancer: Overall, the top-five frequently mutated cancer genes across human cancers were TP53 (36.6%), MUC16 (18.9%), CSMD3 (13.7%), LRP1B (13.5%), and PIK3CA (12.4%) (Fig. 2g).